ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,595.76
      0.75%
      US Tech 100
      18,928.80
      0.00%
      Dow Jones
      41,096.77
      0.58%
      Brent Oil
      72.03
      0.08%
      Bitcoin
      58,059.12
      -0.13%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. InflaRx NV (IFRX) Quote

      InflaRx NV

      InflaRx NV (IFRX)

      NASDAQ
      1.44
      0.00
      (0.00%)
      Closed September 13 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.44
      Bid
      1.39
      Ask
      1.46
      Volume
      -
      0.00 Day's Range 0.00
      0.7762 52 Week Range 7.2499
      Market Cap
      84.792M
      Previous Close
      1.44
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      140,366
      Shares Outstanding
      58,883,272
      Dividend Yield
      -
      PE Ratio
      -1.99
      Earnings Per Share (EPS)
      -0.72
      Revenue
      63k
      Net Profit
      -42.67M

      About InflaRx NV

      InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator in... InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.inflarx.de
      Headquarters
      Jena, Deu
      Founded
      -
      InflaRx NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IFRX. The last closing price for InflaRx NV was $1.44. Over the last year, InflaRx NV shares have traded in a share price range of $ 0.7762 to $ 7.2499.

      InflaRx NV currently has 58,883,272 shares outstanding. The market capitalization of InflaRx NV is $84.79 million. InflaRx NV has a price to earnings ratio (PE ratio) of -1.99.

      Ask ADVFN Intelligence (AI)

      IFRX Latest News

      More News

      InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases

      JENA, Germany, Sept. 03, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...

      September 03 2024
      GlobeNewswire Inc.

      InflaRx Announces Participation in September Investor Events

      JENA, Germany, Aug. 27, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

      August 27 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 08 2024
      Edgar (US Regulatory)

      InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update

      Hosted research and development (R&D) event focused on the differentiation of INF904 and its potential in addressing significant unmet needs in inflammation & immunology...

      August 08 2024
      GlobeNewswire Inc.

      InflaRx to Report Second Quarter 2024 Results on August 8, 2024

      JENA, Germany, Aug. 01, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

      August 01 2024
      GlobeNewswire Inc.

      InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases

      JENA, Germany, July 30, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...

      July 30 2024
      GlobeNewswire Inc.

      InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)

      JENA, Germany, June 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced...

      June 24 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      June 05 2024
      Edgar (US Regulatory)

      InflaRx Hosts R&D Event Highlighting the Promise of INF904

      Thought leaders in complement inhibition, chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) provide compelling new insights into the strong development rationales, potential...

      June 05 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 21 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.075.109489051091.371.691.27755511.52043513CS
      4-0.05-3.355704697991.491.77091.23699331.55003278CS
      12-0.12-7.692307692311.561.841.1651403661.49545949CS
      26-2.54-63.81909547743.984.091.142242081.60769807CS
      52-1.5-51.02040816332.947.24990.77626481693.91402779CS
      156-1.59-52.47524752483.039.70.77626137674.22050555CS
      2600001.58000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.133
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 62.3698
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.77
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 9.75
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.5108
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.133
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 62.3698
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.77
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 9.75
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.5108
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.133
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 62.3698
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.77
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 9.75
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.5108
      (0.00%)
      		0

      IFRX Discussion

      View Posts
      Monksdream Monksdream 1 month ago
      IFRX 10Q due AUGUST5
      👍️0
      Monksdream Monksdream 2 months ago
      IFRX under $2
      👍️0
      Monksdream Monksdream 2 months ago
      IFRX under $2
      👍️0
      glenn1919 glenn1919 3 months ago
      IFRX..................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      ralfito ralfito 3 months ago
      What is up with IFRX? Seems to be teetering. Numbers look good, except for Forward EPS.
      👍️0
      glenn1919 glenn1919 4 months ago
      IFRX...............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 5 months ago
      IFRX under $2
      👍️0
      Monksdream Monksdream 6 months ago
      IFRX under $2
      👍️0
      glenn1919 glenn1919 6 months ago
      IFRX................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 7 months ago
      IFRX under $2
      👍️0
      Monksdream Monksdream 10 months ago
      IFRX new 52 week low
      👍️0
      TheFinalCD TheFinalCD 10 months ago
      https://finviz.com/quote.ashx?t=IFRX&ty=c&ta=1&p=d

      does have a REGISTERED SHELF OFFERING

      https://dilutiontracker.com/app/search/IFRX?a=dbb88c

      Apr-05-23 Upgrade Guggenheim Neutral ? Buy $8
      👍️0
      enthalpy enthalpy 1 year ago
      True waiting on that skin cancer p2 data release or EUA sales update.
      👍️0
      peterus peterus 1 year ago
      going the wronge way
      👍️0
      peterus peterus 1 year ago
      yup $10+ coming
      👍️0
      enthalpy enthalpy 1 year ago
      I added more and its a decent position. I think we have a shot at 10 to 15 short term. Friday looked promising. Hopefully we get a second wave to start in 2 weeks.
      👍️0
      peterus peterus 1 year ago
      you still in ????
      im still holding 4s
      👍️0
      Gator44 Gator44 1 year ago
      Closing of offering, here comes first stop $6.25
      👍️0
      frans frans 1 year ago
      IFRX should go slowly 5$ +
      👍️0
      frans frans 1 year ago
      IFRX 4.2 now slowly on the move
      👍️0
      frans frans 1 year ago
      in here at 4.10
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Still in downtrend and they will keep diluting
      👍️0
      enthalpy enthalpy 1 year ago
      I bought more 4.04
      👍️0
      Gator44 Gator44 1 year ago
      Couple of pennies are cloce enough
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Learn your charts lol $3.93 is the gap fill
      👍️0
      Gator44 Gator44 1 year ago
      Gap filled boys and girls...
      Big boy buying today !!!
      👍️0
      peterus peterus 1 year ago
      dont think we will see 3.50s
      but it could happen with this market
      👍️0
      enthalpy enthalpy 1 year ago
      Whats your thoughts on it hitting 3.50?
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      When it hits $3.93 tomorrow is where I’ll be buying my first order
      👍️0
      enthalpy enthalpy 1 year ago
      Tomorrow we probably hit 3.75ish and that's close enough to the 62% fibonacci pullback. If it hits 3.75 rsi will be around mid 50s give or take which is good.
      👍️0
      enthalpy enthalpy 1 year ago
      Probably right. I loaded some at 4.20 with rsi at 61 but i think 3.75 is the target. Glta.
      👍️0
      peterus peterus 1 year ago
      beter on side line and buy bottom
      👍️0
      peterus peterus 1 year ago
      it wil but not today
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      I thought you said going to $10 lol now you’re on the sideline this going to test the gaps fill $3.93
      👍️0
      peterus peterus 1 year ago
      im still on side line
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      I disagree I’m going to be buying at $3.93 that’s the gap fill
      👍️0
      peterus peterus 1 year ago
      4.40s 4.50s could be stronge support
      👍️0
      peterus peterus 1 year ago
      agree
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Ok today we will see $4 first step
      👍️0
      peterus peterus 1 year ago
      lol will never see $2 maybe in your dreams lol
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Lol ?? you’re delusional major diluting down to $2
      👍️0
      enthalpy enthalpy 1 year ago
      I will be loading on the 10 million share offering. Looking for $3.50ish.
      👍️0
      RobP33 RobP33 1 year ago
      New highs by EOW???
      👍️0
      enthalpy enthalpy 1 year ago
      Only had 2 minutes missed the 4.60 buy.
      👍️0
      enthalpy enthalpy 1 year ago
      We will see i have 1/3 of position bet at $5.00 but im playing this by the book.
      👍️0
      peterus peterus 1 year ago
      yup i think you could be right
      👍️0
      enthalpy enthalpy 1 year ago
      Fibonacci 38% pull back is $5.00 and 62% pull back is around $4.00. 78% is even further. Either one works. I flipped once for a big win but i think the second wave over several weeks will take this over $12.00.
      👍️0
      peterus peterus 1 year ago
      fliped out
      side line ... waiting
      👍️0
      enthalpy enthalpy 1 year ago
      Waiting for $4.00. Enjoy the ride down.
      👍️0
      enthalpy enthalpy 1 year ago
      Picked up 1/4 at 5.00. Waiting for rest around low 4.00ish.
      👍️0

      Your Recent History

      NASDAQ
      IFRX
      InflaRx NV
      Delayed Upgrade Clock